Rossari Biotech Limited — Others, 26-04-2025: Copy of Newspaper Publication

Rossari Biotech Limited has announced a board meeting on April 25, 2025, to discuss the consolidated audited financial results for the quarter and financial year ended March 31, 2025. The quarterly total income from operations is reported at ₹579.50 crore (cr), with a net profit of ₹344.44 crore (cr). For the full-year results, total income stands at ₹2,000.29 crore (cr) and net profit at ₹1,363.11 crore (cr). This strong performance reflects the company's robust operational efficiency and growth strategies, potentially enhancing investor sentiment towards its financial stability and market position, positioning the company favorably for future opportunities.